borderline significantp = 0.061
After six months of treatment with PCSK9i FMD correlated with systolic blood pressure ( r = -0.286; p = 0.004) and VCAM1 ( r = -0.229; p = 0.024), while correlation with age was borderline significant ( r = 0.319; p = 0.061).